Literature DB >> 26965416

Why don't patients take their analgesics? A meta-ethnography assessing the perceptions of medication adherence in patients with osteoarthritis.

T Dockerty1, S K Latham2, T O Smith3.   

Abstract

Whilst analgesics and medications have demonstrated efficacy for people with osteoarthritis, their effectiveness is dependent on adherence. This has previously been reported as particularly low in this population. The purpose of this meta-ethnography was to explore possible perceptions for this. A systematic review of published and unpublished literature was undertaken. All qualitative studies assessing the attitudes or perceptions of people with osteoarthritis towards medication adherence were eligible. Study quality was assessed using the Critical Appraisal Skills Programme qualitative tool. Analysis was undertaken using a meta-ethnography approach, distilling to a third-order construct and developing a line of argument. From 881 citations, five studies met the eligibility criteria. The meta-ethnography generated a model where medication adherence for people with osteoarthritis is perceived as a balance between the willingness and preference to take medications with the alterative being toleration of symptoms. Motivators to influence this 'balance' may fluctuate and change over time but include: severity of symptoms, education and understanding of osteoarthritis and current medications, or general health which may raise issues for poly-pharmacy as other medications are added or substituted into the patient's formulary. Medicine adherence in people with osteoarthritis is complex, involving motivators which will fluctuate in impact on individuals at different points along the disease progression. Awareness of each motivator may better inform clinicians as to what education, support or change in prescription practice should be adopted to ensure that medicine adherence is individualised to better promote long-term behaviour change.

Entities:  

Keywords:  Compliance; Drug; Elderly; Musculoskeletal; Systematic review

Mesh:

Substances:

Year:  2016        PMID: 26965416     DOI: 10.1007/s00296-016-3457-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  [Guidelines for the management of knee and hip osteoarthritis: For whom? Why? To do what?].

Authors:  Yves Henrotin; Xavier Chevalier
Journal:  Presse Med       Date:  2010-09-16       Impact factor: 1.228

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

3.  The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.

Authors:  Marita Cross; Emma Smith; Damian Hoy; Sandra Nolte; Ilana Ackerman; Marlene Fransen; Lisa Bridgett; Sean Williams; Francis Guillemin; Catherine L Hill; Laura L Laslett; Graeme Jones; Flavia Cicuttini; Richard Osborne; Theo Vos; Rachelle Buchbinder; Anthony Woolf; Lyn March
Journal:  Ann Rheum Dis       Date:  2014-02-19       Impact factor: 19.103

4.  How "bad" does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis.

Authors:  Joanna E M Sale; Monique Gignac; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2006-04-15

5.  OARSI guidelines for the non-surgical management of knee osteoarthritis.

Authors:  T E McAlindon; R R Bannuru; M C Sullivan; N K Arden; F Berenbaum; S M Bierma-Zeinstra; G A Hawker; Y Henrotin; D J Hunter; H Kawaguchi; K Kwoh; S Lohmander; F Rannou; E M Roos; M Underwood
Journal:  Osteoarthritis Cartilage       Date:  2014-01-24       Impact factor: 6.576

Review 6.  How to define responders in osteoarthritis.

Authors:  Cyrus Cooper; Jonathan D Adachi; Thomas Bardin; Francis Berenbaum; Bruno Flamion; Helgi Jonsson; John A Kanis; Franz Pelousse; Willem F Lems; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Susanne Reiter; Jean-Yves Reginster; René Rizzoli; Olivier Bruyère
Journal:  Curr Med Res Opin       Date:  2013-04-17       Impact factor: 2.580

Review 7.  Attitudes of people with osteoarthritis towards their conservative management: a systematic review and meta-ethnography.

Authors:  Toby O Smith; Rachel Purdy; Sarah Lister; Charlotte Salter; Robert Fleetcroft; Philip G Conaghan
Journal:  Rheumatol Int       Date:  2013-12-05       Impact factor: 2.631

8.  Role of health education and self-action plan in improving the drug compliance in bronchial asthma.

Authors:  Gajanan S Gaude; Jyothi Hattiholi; Alisha Chaudhury
Journal:  J Family Med Prim Care       Date:  2014-01

9.  Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS).

Authors:  Tracey-Lea Laba; Jo-anne Brien; Marlene Fransen; Stephen Jan
Journal:  BMC Musculoskelet Disord       Date:  2013-05-06       Impact factor: 2.362

10.  Conducting a meta-ethnography of qualitative literature: lessons learnt.

Authors:  Salla Atkins; Simon Lewin; Helen Smith; Mark Engel; Atle Fretheim; Jimmy Volmink
Journal:  BMC Med Res Methodol       Date:  2008-04-16       Impact factor: 4.615

View more
  8 in total

Review 1.  Move it or Lose it. Is it Reasonable for Older Adults with Osteoarthritis to Continue to Use Paracetamol in Order to Maintain Physical Activity?

Authors:  Kayla Lee; Julie Cooke; Gabrielle Cooper; Alison Shield
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

2.  Living life precariously with rheumatoid arthritis - a mega-ethnography of nine qualitative evidence syntheses.

Authors:  Fran Toye; Kate Seers; Karen Louise Barker
Journal:  BMC Rheumatol       Date:  2019-02-06

3.  Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence.

Authors:  Sonal Ghura Mansukhani; Elizabeth A MacLean; Laura L Manzey; Carl J Possidente; Joseph C Cappelleri; Linda S Deal
Journal:  Patient Prefer Adherence       Date:  2021-09-09       Impact factor: 2.711

4.  Incorporating patient preferences into osteoarthritis treatment.

Authors:  Yeşim Gökçe Kutsal; Sibel Eyigör; Sevilay Karahan; Rezzan Günaydın; Jale İrdesel; Merih Sarıdoğan; Pınar Borman; Aylin Sarı; Kutay Ordu Gökkaya; Vildan Binay Safer
Journal:  Arch Rheumatol       Date:  2021-10-16       Impact factor: 1.472

5.  Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Developed for Use in a Range of Diseases, Treatment Modalities, and Countries.

Authors:  Sarah Bentley; Lucy Morgan; Elizabeth Exall; Rob Arbuckle; Rebecca C Rossom; Nicholas Roche; Kamlesh Khunti; Victoria Higgins; James Piercy
Journal:  Patient Prefer Adherence       Date:  2022-09-15       Impact factor: 2.314

6.  Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising.

Authors:  Bridget J Kelly; Douglas J Rupert; Kathryn J Aikin; Helen W Sullivan; Mihaela Johnson; Carla M Bann; Nicole Mack; Brian G Southwell; Sue West; Sarah Parvanta; Alexander Rabre; Susana Peinado
Journal:  Res Social Adm Pharm       Date:  2020-08-06

Review 7.  Therapeutic potential of mesenchymal stem cell based therapy for osteoarthritis.

Authors:  John Burke; Monte Hunter; Ravindra Kolhe; Carlos Isales; Mark Hamrick; Sadanand Fulzele
Journal:  Clin Transl Med       Date:  2016-08-10

Review 8.  An Adaptable Framework for Factors Contributing to Medication Adherence: Results from a Systematic Review of 102 Conceptual Frameworks.

Authors:  Kai Qi Elizabeth Peh; Yu Heng Kwan; Hendra Goh; Hasna Ramchandani; Jie Kie Phang; Zhui Ying Lim; Dionne Hui Fang Loh; Truls Østbye; Dan V Blalock; Sungwon Yoon; Hayden Barry Bosworth; Lian Leng Low; Julian Thumboo
Journal:  J Gen Intern Med       Date:  2021-03-03       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.